In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Aronex assumes investigational NDA for Aroplatin
Aronex reports responses using ATRAGEN as a treatment for non-Hodgkin's lymphoma
Ribozyme Pharmaceuticals initiates Angiozyme clinical
Valentis initiates gene therapy clinical trial
Repligen initiates secretin clinical trials
Cerus initiates second clinical infective inactivation infusion study
Lilly initiates clinical trials on second cancer drug discovered in Isis collaboration